Pathophysiology, Diagnosis, and Management of Coronary Artery Disease In the Setting of Atrial Fibrillation

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 22

PMID 39575708

Authors

Georgiana Pintea Bentea

Brahim Berdaoui

Marielle Morissens

Philippe van de Borne

Jose Castro Rodriguez

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) and coronary artery disease are frequently associated and, when so, lead to a grim prognosis. Recent studies suggest the presence of interconnected pathophysiological pathways between the 2 conditions that can promote and aggravate each other, igniting a vicious cycle. Notwithstanding, in contrast with the attention dedicated to the management of antithrombotic treatment, research on other aspects of coronary artery disease in AF is only recently gaining traction. The clinical impact of correct assessment of coronary artery stenosis in AF is especially high, due to the antithrombotic therapy imposed by both AF and coronary stenting. Until recently, an in-depth characterization of coronary microcirculation in AF was lacking. However, contemporary studies indicate that coronary microvascular dysfunction is a frequent encounter in AF, possibly explaining the ischemic symptoms even in the absence of obstructive coronary artery disease and interfering with the use of pressure-based indices to evaluate the hemodynamic significance of coronary artery stenosis. This comprehensive review addresses our current knowledge on coronary physiology in AF and its repercussion on the invasive management of coronary artery disease in this setting.

Citing Articles

Automatic Detection of Occluded Main Coronary Arteries of NSTEMI Patients with MI-MS ConvMixer + WSSE Without CAG.

Goktekin M, Gul E, Cakmak T, Demir F, Kobat M, Akbulut Y Diagnostics (Basel). 2025; 15(3).

PMID: 39941277 PMC: 11817353. DOI: 10.3390/diagnostics15030347.

The Pathophysiology and Vascular Complications of Diabetes in Chronic Kidney Disease: A Comprehensive Review.

Hauwanga W, Abdalhamed T, Ezike L, Chukwulebe I, Ko Oo A, Wilfred A Cureus. 2025; 16(12):e76498.

PMID: 39872596 PMC: 11770394. DOI: 10.7759/cureus.76498.

References

Derimay F, Johnson N, Zimmermann F, Adjedj J, Witt N, Hennigan B . Predictive factors of discordance between the instantaneous wave-free ratio and fractional flow reserve. Catheter Cardiovasc Interv. 2019; 94(3):356-363. DOI: 10.1002/ccd.28116. View

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

Liang F, Wang Y . Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2020; 320(1):H1-H12. DOI: 10.1152/ajpheart.00702.2020. View

Zusman O, Amit G, Gilutz H, Zahger D . The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol. 2011; 101(1):17-22. DOI: 10.1007/s00392-011-0357-5. View

Lopes R, Heizer G, Aronson R, Vora A, Massaro T, Mehran R . Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019; 380(16):1509-1524. DOI: 10.1056/NEJMoa1817083. View

Fiedler K, Maeng M, Mehilli J, Schulz-Schupke S, Byrne R, Sibbing D . Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial. J Am Coll Cardiol. 2015; 65(16):1619-1629. DOI: 10.1016/j.jacc.2015.02.050. View

Soliman E, Lopez F, ONeal W, Chen L, Bengtson L, Zhang Z . Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015; 131(21):1843-50. PMC: 4447576. DOI: 10.1161/CIRCULATIONAHA.114.014145. View

Hunter R, Berriman T, Diab I, Kamdar R, Richmond L, Baker V . A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014; 7(1):31-8. DOI: 10.1161/CIRCEP.113.000806. View

Corban M, Godo S, Burczak D, Noseworthy P, Toya T, Lewis B . Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation. J Am Heart Assoc. 2020; 9(8):e014850. PMC: 7428536. DOI: 10.1161/JAHA.119.014850. View

10.

Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T . The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98(5):476-84. DOI: 10.1016/S0002-9343(99)80348-9. View

11.

Zhang P, Shao L, Ma J . Toll-Like Receptors 2 and 4 Predict New-Onset Atrial Fibrillation in Acute Myocardial Infarction Patients. Int Heart J. 2018; 59(1):64-70. DOI: 10.1536/ihj.17-084. View

12.

Nolte F, van de Hoef T, Meuwissen M, Voskuil M, Chamuleau S, Henriques J . Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia. EuroIntervention. 2014; 9(12):1423-31. DOI: 10.4244/EIJV9I12A240. View

13.

Avitall B, Bi J, Mykytsey A, Chicos A . Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. Heart Rhythm. 2008; 5(6):839-45. DOI: 10.1016/j.hrthm.2008.02.042. View

14.

Mekhael M, Marrouche N, El Hajjar A, Donnellan E . The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators. Trends Cardiovasc Med. 2022; 34(2):91-98. DOI: 10.1016/j.tcm.2022.09.006. View

15.

Pintea Bentea G, Berdaoui B, Samyn S, Morissens M, van de Borne P, Castro Rodriguez J . Major Adverse Cardiac Events After Fractional Flow Reserve, Instantaneous Wave-Free Ratio, or Angiography-Guided Revascularization in Atrial Fibrillation: A Retrospective Study. Am J Cardiol. 2024; 211:69-71. DOI: 10.1016/j.amjcard.2023.10.072. View

16.

Corley S, Epstein A, DiMarco J, Domanski M, Geller N, Greene H . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004; 109(12):1509-13. DOI: 10.1161/01.CIR.0000121736.16643.11. View

17.

Lip G, Beevers D . ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ. 1995; 311(7016):1361-3. PMC: 2551280. DOI: 10.1136/bmj.311.7016.1361. View

18.

Kannel W, Abbott R, Savage D, MCNAMARA P . Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982; 306(17):1018-22. DOI: 10.1056/NEJM198204293061703. View

19.

McManus D, Rienstra M, Benjamin E . An update on the prognosis of patients with atrial fibrillation. Circulation. 2012; 126(10):e143-6. PMC: 3678907. DOI: 10.1161/CIRCULATIONAHA.112.129759. View

20.

Kralev S, Schneider K, Lang S, Suselbeck T, Borggrefe M . Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One. 2011; 6(9):e24964. PMC: 3177852. DOI: 10.1371/journal.pone.0024964. View